賽意信息(300687.SZ)擬向銀行申請辦理不超1000萬元保函及備用信用證業務
格隆匯 12 月 28日丨賽意信息(300687.SZ)公佈,公司於2020年12月26日召開的第二屆董事會第二十九次會議以全票同意的表決結果審議通過了《關於向銀行申請辦理保函及備用信用證業務的議案》。
公司為滿足日常經營業務開展需要,向中國工商銀行股份有限公司廣州花城支行申請辦理金額不超過1000萬元的非融資性保函及備用信用證業務,擔保方式為100%保證金或一定比例保證金作質押擔保。有效期為一年。
公司可以在董事會審議通過之日起一年內申請辦理上述保函及備用信用證業務。
公司董事會授權總經理張成康先生簽署上述保函及備用信用證業務相關文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.